Skip to main content
TipRanks
Go Ultimate75% OFF

Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft Unsponsored ADR (MUVB) Q3 2026 Earnings Report

3 Followers

DE:MUVB Q3 2026 EPS Results

Actual EPS
EUR 0.20
Consensus EPS
EUR 0.23
Beat/Miss
Missed by -EUR 0.03
One Year Ago EPS
EUR 0.32

DE:MUVB Q3 2026 Revenue Results

Actual Revenue
―
Expected Revenue
EUR 16.34B
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q3 2026
Date
11/12/2026
Time
Before Open
Conference Call
Thursday, November 12, 2026
DE:MUVB Upcoming Earnings

Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft Unsponsored ADR's next earnings date is estimated for February 25, 2027, based on past reporting schedules.

Q3 2026 Earnings Call Audio

DE:MUVB Q3 2026 Earnings Call
0:00 / 0:00

Q3 2026 Earnings Slide Deck

Q3 2026 Earnings Call Summary

Q3 2026
Earnings Call Date:Nov 12, 2026|% Change Since:―|
Earnings Call Sentiment|Positive

The call was strongly positive overall. Munich Re reported a EUR 1.7 billion Q3 result and EUR 5.7 billion after nine months, raised full-year guidance to EUR 6.6 billion, and expects to exceed its annual profit target for the sixth consecutive year. Reinsurance and ERGO operations generally performed ahead of plan, solvency remained very strong at 301%, and management highlighted profitable growth, higher reinvestment yields, and selective M&A. The main challenges were lower ERGO investment returns from rising bond yields, cautious reserving, an elevated but partly temporary discounting benefit, a rising normalized P&C combined ratio, and expected downward pricing pressure in upcoming renewals.

Company Guidance

Munich Re raised full-year net result guidance to EUR 6.6 billion, expects to exceed its annual profit target for the sixth consecutive year, and said life and health reinsurance remains on track for full-year guidance of EUR 1.9 billion; P&C reinsurance is expected to beat full-year guidance after a headline actual combined ratio of 72.2% after nine months, while GSI is expected to beat full-year guidance after achieving a combined ratio below 86% for the first nine months, and ERGO International’s P&C combined ratio of 89% met full-year guidance. The group’s return on investment was 3.9% after nine months and remained within full-year guidance, with 3.5% described as the overall target for return on investment; sustainable running yield was indicated as something more like 3.7%, with maybe potential for some upwards drift, while 4% was not yet a permanent level. The normalized combined ratio may continue its upward trend in Q4, with continued upwards pressure from recent renewals and the large deal, and the 18% outlier guidance for this year was described as probably higher than it needs to be. The financial outlook for 2027 will be disclosed on December 10th.

  • Strong Q3 and Nine-Month Net ResultsMunich Re reported a Q3 net result of EUR 1.7 billion and a nine-month net result of EUR 5.7 billion, described as another particularly strong quarter and the sixth consecutive year in which the company is expected to exceed its annual profit target.
  • Raised Full-Year Net Result GuidanceThe company raised its full-year 2026 net result guidance to EUR 6.6 billion, with the increase coming from the reinsurance business field. Management said the accounts should reflect the strong performance achieved during the year.
  • Revenue Growth and Progress Toward GuidanceCurrency-adjusted revenue grew by almost 5% year-on-year in the first nine months. Management said the company is making good progress toward its revised revenue guidance, primarily driven by strong new business in life and health reinsurance and inorganic growth at ERGO International.
  • Strong Reinsurance Investment PerformanceReinsurance return on investment was 4.7% in Q3, supported by interest-rate derivatives positioned to benefit from higher rates and a positive contribution from commodity investments. Group return on investments was 3.2% in Q3 and 3.9% after nine months, remaining within full-year guidance.
  • Higher Reinvestment Yield and Future Income TailwindHigher interest rates lifted the reinvestment yield by 40 basis points during Q3. The company repositioned its fixed-income portfolio toward attractive yields, and the running yield remained at 4.0%, the same high level as the prior quarter. Management said higher yields should gradually feed into investment income and provide a tailwind for next year's earnings.
  • Life and Health Reinsurance Ahead of PlanLife and health reinsurance delivered a total technical result of EUR 493 million in Q3, above the pro rata amount needed to meet the annual ambition. The performance was supported by positive biometric experience, mainly mortality, and the company remains well on track to achieve its full-year guidance of EUR 1.9 billion.
  • Life and Health New Business and CSM GrowthThe stock of life reinsurance contractual service margin increased further, driven by new business growth and the recognition of further large transactions in Q3. Management said this provides a strong foundation for sustainably high technical results.
  • P&C Reinsurance Combined Ratio and GuidanceP&C reinsurance reported a Q3 combined ratio of 80%, including major losses somewhat below the expected level. The nine-month headline actual combined ratio was 72.2%, and management expects to beat its full-year P&C reinsurance guidance.
  • P&C Revenue ResilienceP&C reinsurance revenue grew by 5% in the standalone third quarter. Management attributed the result primarily to a modest foreign-exchange tailwind, followed by the continued earn-in of a large structured transaction, with modest organic growth also contributing. The structured transaction came in faster than anticipated and is expected to reach an equilibrium level around year-end.
  • Global Specialty Insurance OutperformanceGlobal Specialty Insurance delivered a combined ratio of 83.9% in Q3, better than expectations and benefiting from benign major losses. The company expects to beat its full-year guidance after achieving a combined ratio below 86% for the first nine months.
  • Strong ERGO Primary Insurance ResultERGO delivered a Q3 net result of EUR 263 million, well above its pro rata guidance. ERGO Germany reported a segment result of EUR 118 million, while ERGO International reported a very strong net result of EUR 145 million.
  • ERGO Technical Performance and GrowthERGO Germany's technical performance in life and health was supported by high CSM release, strong PAA business contribution, and continued profitable growth. ERGO Germany P&C reported an 89.8% combined ratio. ERGO International's life and health technical profitability significantly exceeded expectations, and its P&C combined ratio was 89%, meeting full-year guidance.
  • ERGO International Consolidation and Organic GrowthERGO International's result benefited from the first-time full consolidation of ERGO China Life Insurance. Management also described organic growth at ERGO Germany as impressive for a large, mature market, with Q3 growth of 11% versus 2% at the half year; an accounting treatment update for premium adjustments in life and health may have contributed.
  • Very Strong Solvency PositionThe Solvency II ratio remained very strong at 301% in Q3. Management said the balance sheet is being put to work through profitable business growth and selective M&A while maintaining a focus on attractive capital returns.
  • Capital Deployment and M&A InitiativesMunich Re intends to continue deploying capital through profitable business growth and selective M&A, including the forthcoming acquisition of At-Bay. Management expects the At-Bay transaction to close early next year, potentially in Q1, subject to the relevant process.
  • Strategic Rationale for At-Bay and ERGO NEXT ProgressManagement said At-Bay's combination of cyber insurance with scanning, monitoring, and incident-response services is strategically relevant for small and medium-sized businesses. Management also said ERGO NEXT is progressing well in volume growth and technical performance and remains committed to reaching break-even by the end of next year.
  • Improved GSI Exposure ManagementManagement credited improved exposure monitoring, geocoding, geolocation, high-definition modeling, and management of the combined footprint across GSI entities for better underwriting performance. The Q3 GSI result was not materially driven by external reinsurance recoveries.
  • Strong German GAAP PositionGerman GAAP results were described as proceeding well and directionally strong. Management said they should support Munich Re's capital return plans in the short to medium term.
  • Normalized Combined Ratio May Understate ProfitabilityManagement said the 18% outlier assumption used in normalized combined ratio calculations is probably higher than needed given the changed business mix. As a result, the normalized combined ratio may understate the underlying profitability of the business slightly, and the company intends to address this for next year.

DE:MUVB Earnings History

DE:MUVB earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 25, 20272026 (Q4)0.19-0.15――
Nov 12, 20262026 (Q3)0.230.200.32-38.72% (-0.13)
Aug 07, 20262026 (Q2)0.300.370.348.60% (+0.03)
May 12, 20262026 (Q1)0.290.280.1760.42% (+0.10)
Feb 26, 20262025 (Q4)0.150.150.156.21% (+0.01)
Nov 11, 20252025 (Q3)0.300.320.13145.89% (+0.19)
Aug 08, 20252025 (Q2)0.280.340.2440.38% (+0.10)
May 13, 20252025 (Q1)0.170.170.31-44.83% (-0.14)
Feb 26, 20252024 (Q4)0.110.150.150.00% (+0.00)
Nov 07, 20242024 (Q3)0.170.130.17-20.65% (-0.03)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed